SELLAS Life Sciences Group Inc buy Wolf_of_WS
Start price
05.03.23
/
50%
€1.52
Target price
05.03.24
-
Performance (%)
-19.55%
End price
17.03.23
€1.22
Summary
This prediction ended on 17.03.23 with a price of €1.22. The prediction for SELLAS Life Sciences Group Inc disappointed with a performance of -19.55%. Wolf_of_WS has 50% into this predictionSELLAS Life Sciences is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, is a cancer immunotherapy being developed for the treatment of acute myeloid leukemia (AML) and ovarian cancer. SELLAS Life Sciences is listed on the NASDAQ stock exchange under the symbol RXII.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| SELLAS Life Sciences Group Inc | 19.816% | 19.816% | 663.583% | 640.741% |
| iShares Core DAX® | 2,57 % | 5,33 % | 8,27 % | 63,86 % |
| iShares Nasdaq 100 | 4,86 % | 0,45 % | 27,08 % | 86,27 % |
| iShares Nikkei 225® | 5,59 % | -0,59 % | 48,55 % | 78,35 % |
| iShares S&P 500 | 3,25 % | 2,50 % | 23,35 % | 68,71 % |
Comments by Wolf_of_WS for this prediction
In the thread SELLAS Life Sciences Group Inc diskutieren
Buy SELLAS Life Sciences Group Inc